Murakami, Takaaki
Fujimoto, Hiroyuki
Hamamatsu, Keita
Yamauchi, Yuki
Kodama, Yuzo
Fujita, Naotaka
Fujikura, Junji
Shimizu, Yoichi
Nakamoto, Yuji
Kimura, Hiroyuki
Saji, Hideo
Inagaki, Nobuya
Funding for this research was provided by:
JSPS KAKENHI (JP18K08475)
Manpei Suzuki Diabetes Foundation
Article History
Received: 11 October 2020
Accepted: 14 July 2021
First Online: 22 July 2021
Competing interests
: N. I. received clinical commissioned/joint research grants from Daiichi Sankyo, Terumo, and Drawbridge Inc.; speaker honoraria from Kowa, MSD, Astellas Pharma, Novo Nordisk Pharma, Ono Pharmaceutical, Nippon Boehringer Ingelheim, Takeda, Eli Lilly Japan, Sumitomo Dainippon Pharma and Mitsubishi Tanabe Pharma; scholarship grants from Kissei Pharmaceutical, Sanofi, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Takeda, Japan Tobacco, Kyowa Kirin, Sumitomo Dainippon Pharma, Astellas Pharma, MSD, Eli Lilly Japan, Ono Pharmaceutical, Sanwa Kagaku Kenkyusho, Nippon Boehringer Ingelheim, Novo Nordisk Pharma, Novartis Pharma, Teijin Pharma, and Life Scan Japan. T.M., K.H., H.F., Y.Y., Y.K., N.F., J.F., Y.S., Y.N., K.H., and H.S. have no conflict of interest to disclose.